TFGT
EW icon

TS Financial Group (TSFG)’s Edwards Lifesciences EW Stock Holding History

TS Financial Group (TSFG)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.32M Sell
69,843
-991
-1% -$83K 0.8% 34
2026
Q1 		$5.67M Sell
70,834
-456
-0.6% -$37.6K 0.86% 34
2025
Q4 		$6.08M Sell
71,290
-314
-0.4% -$25.8K 0.91% 32
2025
Q3 		$5.57M Sell
71,604
-496
-0.7% -$38.8K 0.88% 32
2025
Q2 		$5.64M Sell
72,100
-2,387
-3% -$178K 1.02% 27
2025
Q1 		$5.4M Sell
74,487
-2,772
-4% -$198K 1.1% 25
2024
Q4 		$5.72M Sell
77,259
-4,783
-6% -$335K 1.17% 26
2024
Q3 		$5.41M Sell
82,042
-5,817
-7% -$423K 1.18% 24
2024
Q2 		$8.12M Buy
87,859
+6,870
+8% +$608K 1.9% 13
2024
Q1 		$7.74M Sell
80,989
-3,959
-5% -$333K 1.95% 14
2023
Q4 		$6.48M Sell
84,948
-625
-0.7% -$43.5K 2.04% 12
2023
Q3 		$5.93M Sell
85,573
-38
-0% -$3.05K 2.11% 12
2023
Q2 		$8.08M Sell
85,611
-2,259
-3% -$196K 3.01% 8
2023
Q1 		$7.27M Buy
87,870
+1,008
+1% +$79.2K 2.7% 9
2022
Q4 		$6.48M Buy
86,862
+956
+1% +$73.7K 2.58% 9
2022
Q3 		$7.1M Buy
85,906
+1,693
+2% +$163K 3.32% 6
2022
Q2 		$8.01M Sell
84,213
-100
-0.1% -$10.4K 3.44% 6
2022
Q1 		$9.93M Sell
84,313
-278
-0.3% -$31.2K 3.6% 6
2021
Q4 		$11M Buy
84,591
+1,365
+2% +$159K 3.81% 5
2021
Q3 		$9.42M Buy
83,226
+488
+0.6% +$55.7K 3.68% 4
2021
Q2 		$8.57M Sell
82,738
-230
-0.3% -$21.7K 3.45% 7
2021
Q1 		$6.94M Sell
82,968
-509
-0.6% -$43K 3.53% 8
2020
Q4 		$7.62M Sell
83,477
-103
-0.1% -$8.54K 4.07% 7
2020
Q3 		$6.67M Sell
83,580
-295
-0.4% -$23K 3.97% 7
2020
Q2 		$5.8M Buy
83,875
+331
+0.4% +$23.5K 3.83% 6
2020
Q1 		$5.25M Sell
83,544
-888
-1% -$64K 4.69% 6
2019
Q4 		$6.57M Sell
84,432
-690
-0.8% -$53.9K 4.86% 4
2019
Q3 		$6.24M Sell
85,122
-2,322
-3% -$163K 4.78% 5
2019
Q2 		$5.38M Buy
87,444
+3,762
+4% +$227K 4.32% 5
2019
Q1 		$5.34M Buy
+83,682
New +$4.78M 4.54% 4

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

TS Financial Group (TSFG)'s EW Position: Q2 2026 in Review

TS Financial Group (TSFG) reduced its Edwards Lifesciences (EW) stake by 1.4% in Q2 2026, selling an estimated $83K and leaving 69,843 shares worth $6.32M. The position accounts for 0.8% of the portfolio, ranked #34.

TS Financial Group (TSFG) first reported a position in EW in Q1 2019 and has held it in 30 quarters since. The position peaked at $11M in Q4 2021. 466 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • TS Financial Group (TSFG) held 69,843 shares of Edwards Lifesciences worth $6.32M as of Q2 2026.
  • TS Financial Group (TSFG) sold 991 Edwards Lifesciences shares in Q2 2026, an estimated $83K.
  • Edwards Lifesciences made up 0.8% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #34 holding.
  • TS Financial Group (TSFG) first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 30 quarters since.
  • TS Financial Group (TSFG)'s Edwards Lifesciences position peaked at $11M in Q4 2021.
  • 466 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.